With Ian Piggin at the helm, Gowling WLG is well established in the mid-market private equity sphere, routinely overseeing multi-jurisdictional acquisitions, equity financings, and fundraising rounds. The industry expertise extends to the healthcare and biotech spheres, with Piggin supporting private equity funds and management teams on acquisitions and exits from London. Neil Hendron has a strong track record in advising on strategic acquisitions and investments, Chris Towle is knowledgeable in disposals, and Christopher Letters is highlighted for his reinvestment focus. Jeremy Millington has expertise in managing public takeovers, and Gareth Baker is also highlighted as key.
Legal 500 Editorial commentary
Key clients
- António Parada
- HydrogenOne Capital Growth plc
- Pioneer Infrastructure Partners II SCSP
- Perwyn Advisors UK Limited
- Valiant FX Topco Limited
- Edmond de Rothschild Equity Opportunities IV SLP
- Mobeus Equity Partners LLP
- Cairngorm Capital LLP
- Gyrus Capital S.A.
Work highlights
Advised FairJourney Biologics founder and CEO, António Parada, on the sale and partial reinvestment of his stake in FairJourney Biologics, alongside existing sponsor GHO Capital, to Partners Group, one of the largest firms in the global private markets industry.
Advised Edmond de Rothschild Equity Opportunities IV SLP, an alternative investment fund, on its participation in the proposed public to private acquisition of Alliance Pharma plc.
Advised Pioneer Infrastructure Partners II SCSp, the second institutional fund managed by Pioneer Point Partners LLP, on its first investment in Yeager Energy B.V.
Practice head
Ian Piggin
Other key lawyers
Neil Hendron; Chris Towle; Christopher Letters; Jeremy Millington; Gareth Baker; Rebecca Burford; Kris Rogers; Katherine Rainwood; Sharon Ayres; Navin Prabhakar; Chris Brierley; Micky Yang; Chelsie Taylor; Róisín Bergin; Siân Dewing